Dosing
Wegovy pill dosage chart and daily instructions
Daily oral Wegovy has an administration routine that matters as much as the tablet strength. It is a prescription treatment, not an over-the-counter substitute for an injection.
The daily tablet schedule
The label starts with 1.5 mg daily for 30 days, then 4 mg daily for 30 days, then 9 mg daily for 30 days, followed by the recommended 25 mg daily maintenance dose. Lower strengths introduce treatment rather than representing the recommended maintenance dose.
If you struggle with a step, ask the clinician how to proceed. Tablet escalation should not be rushed to chase a trial result, and a previous injectable dose does not authorize skipping the initiation schedule. The label contains specific switching instructions that a prescriber must apply.
| Period | Daily tablet |
|---|---|
| Days 1–30 | 1.5 mg |
| Days 31–60 | 4 mg |
| Days 61–90 | 9 mg |
| From day 91 | 25 mg maintenance, as prescribed |
Sources: Wegovy prescribing information, including tablets and Wegovy HD
Morning routine and missed tablets
Swallow the tablet whole with up to 4 ounces of water in the morning on an empty stomach. Do not crush, chew, dissolve, or split it. Wait at least 30 minutes before breakfast, coffee, other beverages, or other oral medicines.
If a daily tablet is missed, skip it and take the next scheduled tablet the following day. Do not double the dose. Discuss a consistent routine and the timing of other medicines with a pharmacist, especially medicines requiring their own fasting schedule.
Sources: Wegovy prescribing information, including tablets and Wegovy HD
Different from Rybelsus and compounded oral products
Oral Wegovy and Rybelsus are separately labeled products. A compounded oral semaglutide product has not passed FDA review as a generic equivalent and cannot borrow the approved product's absorption or clinical evidence.
Your clinician should assess contraindications, other medicines, pregnancy plans, and whether the fasting routine is practical. Tablets are not automatically safer than injections, and the current Wegovy label advises against breastfeeding during tablet treatment.
Sources: Wegovy prescribing information, including tablets and Wegovy HD · Rybelsus and Ozempic tablets prescribing information · FDA concerns with unapproved GLP-1 drugs used for weight loss
Safety before any dose change
These medicines have boxed warnings about thyroid C-cell tumors observed in rodents; whether the same risk occurs in humans is unknown. Personal or family history of medullary thyroid carcinoma or MEN 2 is a contraindication. This is different from saying that every thyroid condition prevents treatment.
Review severe stomach problems, previous pancreatitis, gallbladder disease, kidney problems, diabetes-related eye disease, pregnancy plans, and all medicines with your prescriber. Insulin or sulfonylureas can increase the risk of low blood sugar when combined with these treatments. Vomiting and diarrhea can cause dehydration and kidney injury.
Severe persistent abdominal pain, inability to keep fluids down, or signs of an allergic reaction require prompt medical assessment. Do not increase a dose to overcome slow weight loss or copy another person's prescription. Tell the anesthesia team about treatment before procedures because delayed gastric emptying can affect aspiration risk.
Sources: Wegovy prescribing information, including tablets and Wegovy HD · Ozempic prescribing information · Zepbound prescribing information · Mounjaro prescribing information
Build the fasting routine into a real morning
A workable routine begins before coffee, breakfast, supplements, or other oral medicines. Take the prescribed tablet whole with no more than four ounces of water, then wait at least 30 minutes before those other items. A full glass of water, taking the tablet with breakfast, or swallowing it alongside a morning pill organizer does not follow the labeled administration instructions.
For a person who must take another medicine on an empty stomach, this creates a scheduling question that deserves a pharmacist's review. Do not simply place both medicines in the same fasting window or delay a necessary medicine without advice. Shift work and travel can also disrupt the routine. Discuss whether you can follow the labeled morning instructions consistently before choosing tablets mainly to avoid needles.
Sources: Wegovy prescribing information, including tablets and Wegovy HD
The first 90 days introduce the maintenance treatment
The 1.5, 4, and 9 mg steps each last 30 days before the recommended 25 mg daily maintenance dose. These are daily strengths, not weekly totals, and the tablet should not be split to create an unprescribed intermediate step. Escalation and tolerability should be reviewed with the prescriber rather than managed by combining leftover strengths.
If nausea or fullness makes eating and drinking difficult, describe the severity and timing before progressing. Avoid judging a starter strength against the long-term trial average: initiation is designed to introduce treatment, while trial outcomes reflect a substantially longer period. A missed tablet is skipped and the next dose taken the following day; doubling the next morning is not a way to preserve the escalation calendar.
Sources: Wegovy prescribing information, including tablets and Wegovy HD
Questions specific to the tablet prescription
Ask whether the prescription is for approved Wegovy tablets, another approved oral semaglutide product, or a compounded preparation. Those names cannot be treated as synonyms. Rybelsus and Ozempic tablets have diabetes indications and separate formulation strengths; a compounded dissolving product does not become Wegovy because a seller uses semaglutide in its description.
Also ask what happens after a prolonged interruption, how a change from injections would be prescribed, and whether coverage applies to this exact formulation. Review pregnancy plans and breastfeeding: the Wegovy label advises against breastfeeding during tablet treatment. Finally, confirm that you can reach the clinician for persistent gastrointestinal symptoms. Removing the injection device removes a technique task, but does not remove the medicine's systemic warnings or the need for ongoing care.
Sources: Wegovy prescribing information, including tablets and Wegovy HD · Rybelsus and Ozempic tablets prescribing information · FDA concerns with unapproved GLP-1 drugs used for weight loss
Sources and evidence
Sources checked October 2, 2026. Prescribing information supports medication facts; provider pages support advertised services. Offers and labels can change.